Bntx stocks.

Based on short-term price targets offered by 14 analysts, the average price target for BioNTech SE Sponsored ADR comes to $135.79. The forecasts range from a low of $101.00 to a high of $200.00 ...609.75M. -85.76%. Get the latest BioNTech SE - ADR (BNTX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment ... BioNTech SE American Depositary Share (BNTX) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.What this means: InvestorsObserver gives Biontech Se ADR (BNTX) an overall rank of 31, which is below average. Biontech Se ADR is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. A rank of 31 means that 69% of stocks appear more favorable to our system.BioNTech Free Cash Flow Forecast for 2023 - 2025 - 2030. In the last three years, Free Cash Flow for BioNTech has grown by 5772.67%, going from $-237.10M to $13.45B. In the coming year, analysts are expecting an increase in Free Cash Flow, predicting it will reach $20.35B – an increase of 51.34%. Over the next eight years, experts anticipate ...

Be the first to know when BNTX insiders and whales buy or sell their stock. Get Free BNTX Updates. BNTX ShareholdersWhat type of owners hold Biontech Se stock? Institutional. Insider. Retail. Name Hold Shares Value Type; Baillie Gifford Co: 3.62%: 8,602,839: $845.66M: Institution: Primecap Management Co: 1.95%: 4,631,963: $455.32M: Institution:Based on short-term price targets offered by 14 analysts, the average price target for BioNTech SE Sponsored ADR comes to $135.79. The forecasts range from a low of $101.00 to a high of $200.00 ...

BioNTech SE. Analyst Report: BioNTech SE BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as ...Nov 15, 2022 · On November 14, 2022, BioNTech SE (NASDAQ:BNTX) stock closed at $160.37 per share. One-month return of BioNTech SE (NASDAQ:BNTX) was 15.42% and its shares lost 35.97% of their value over the last ...

What this means: InvestorsObserver gives Biontech Se ADR (BNTX) an overall rank of 29, which is below average. Biontech Se ADR is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. A rank of 29 means that 71% of stocks appear more favorable to our system.Apple Inc. Common Stock. $180.07 -0.12 -0.07%. Find the latest dividend history for BioNTech SE American Depositary Share (BNTX) at Nasdaq.com.Yet, dig a little deeper and Moderna (MRNA-1.02%) and BioNTech (BNTX-1.99%) differ in important ways. They began differently, they are managed differently, and the path they are taking post-COVID ...BioNTech stock (NASDAQ: BNTX), a leader in messenger RNA technology and Pfizer’s Covid-19 vaccine partner, declined by almost 31% over the last month, considerably underperforming the S&P 500 ...A monster revenue miss was the big reason for the widespread investor sell-off in BioNTech ( BNTX 0.89%) stock on Monday. As of late-session trading that day, the once-hot biotech's share price ...

Get BioNTech SE (BNTX.O) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments

BioNTech (NASDAQ: BNTX), a leader in messenger RNA technology and Pfizer’s Covid-19 vaccine partner, has seen its stock rally from about $80 at the end of 2020 to levels of almost $420 currently ...

2 days agoBioNTech stock (NASDAQ: BNTX), a leader in messenger RNA technology and Pfizer’s Covid-19 vaccine partner, declined by almost 31% over the last month, considerably underperforming the S&P 500 ...BNTX Earnings Date and Information. BioNTech last issued its quarterly earnings results on November 6th, 2023. The reported $0.67 earnings per share for the quarter, topping the consensus estimate of ($0.59) by $1.26. The business earned $895.30 million during the quarter, compared to analyst estimates of $850.50 million.BioNTech SE American Depositary Share (BNTX, $99.25) entered Downtrend as Momentum indicator drops below 0 level on Nov 29, 2023. Tickeron - Stocks. Track BioNTech SE - ADR (BNTX) Stock Price, Quote, latest community messages, chart, news and other stock related information.BioNTech Free Cash Flow Forecast for 2023 - 2025 - 2030. In the last three years, Free Cash Flow for BioNTech has grown by 5772.67%, going from $-237.10M to $13.45B. In the coming year, analysts are expecting an increase in Free Cash Flow, predicting it will reach $20.35B – an increase of 51.34%. Over the next eight years, experts anticipate ...Nasdaq provides market information before market opens daily from 4:15 A.M. ET to 7:30 A.M. ET on the following day. $82.33 -0.02 -0.02%. -0.07. $180.07. BioNTech SE American Depositary Share ...Find the latest BioNTech SE (BNTX) stock quote, history, news and other vital information to help you with your stock trading and investing.

Nov 29, 2023 · The share price of BioNTech SE (BNTX) now. What analysts predict: $142.42. 52-week High/Low: $188.99 / $88. 50/200 Day Moving Average: $101.74 / $113.19. This figure corresponds to the Average Price over the previous 50/200 days. For BioNTech stocks, the 50-day moving average is the resistance level today. Understanding stock price lookup is a basic yet essential requirement for any serious investor. Whether you are investing for the long term or making short-term trades, stock price data gives you an idea what is going on in the markets.Shares of BioNTech (BNTX-1.01%) were 9.1% lower as of 11:51 a.m. EDT on Thursday. The German biotech didn't report any news, so why did its stock slide? ... But stocks that share common ...Börse Frankfurt-News . Funds: Tech stocks at a high - good demand . Price gains of 40 percent since the beginning of the year - that puts technology funds in a buying mood. Broadly diversified equity funds, on the other hand, are seeing profit-taking. And real estate funds continue to be sold off.Nowadays finding high-quality stock photos for personal or commercial use is very simple. You just need to search the photo using a few descriptive words and let Google do the rest of the work.

609.75M. -85.76%. Get the latest BioNTech SE - ADR (BNTX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment ... The analysts downgraded the stock to an Underweight rating from Neutral, with a price target of $99.00, down from the prior $106.00. J.P. Morgan notes the market's cautious stance on the company's ...

Mar 31, 2022 · See if BNTX stock is a buy or sell after earnings. BioNTech has had an excellent 2021. 2022 and beyond will most likely not be this good, however. See if BNTX stock is a buy or sell after earnings. BioNTech (NASDAQ:BNTX), the partner of Pfizer (NYSE:PFE) for the blockbuster COVID vaccine Comirnaty is on track to introduce a COVID-19 shot adjusted for currently dominant strains in line with ...Additionally, the market prices BNTX at a forward multiple of 20.52. As a discount to projected earnings, BioNTech ranks better than 66.67% of companies listed in the biotech space. Thus, forward ...BNTX Stock: Mixed Performance and Challenges in Profitability and Growth. On November 6, 2023, BNTX stock showed mixed performance based on the available data. BNTX is a company in the Health Technology sector, specifically in the Biotechnology industry. With a market cap of $23.2 billion, BNTX is a significant player in the biotech field.BioNTech SE (BNTX) Latest Stock News & Headlines - Yahoo Finance U.S. markets closed +26.83 +294.61(+0.82%) Nasdaq +78.81(+0.55%) Russell 2000 +53.62(+2.96%) Crude Oil 74.38 -1.58(-2.08%) Gold...Find out why BNTX stock is a Buy. BioNTech is quite undervalued after backing out its tremendous and growing cash hoard garnered from its COVID vaccine windfall. Find out why BNTX stock is a Buy.According to the issued ratings of 10 analysts in the last year, the consensus rating for BioNTech stock is Hold based on the current 6 hold ratings and 4 buy ratings for BNTX. The average twelve-month price prediction for BioNTech is $153.69 with a high price target of $260.00 and a low price target of $111.00.5 Stocks Set to Double Each was handpicked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2021. Previous recommendations have soared +143.0%, +175.9%, +498.3% and +673.0%.Coupang Inc. Last on the list, Coupang Inc. is a high-profile recent IPO stock to watch. It was the largest foreign company offering since Alibaba ( NYSE: BABA) came public in 2014. The South ...A monster revenue miss was the big reason for the widespread investor sell-off in BioNTech ( BNTX 0.89%) stock on Monday. As of late-session trading that day, the once-hot biotech's share price ...

The share price of BioNTech SE (BNTX) now. What analysts predict: $142.42. 52-week High/Low: $188.99 / $88. 50/200 Day Moving Average: $101.74 / $113.19. This figure corresponds to the Average Price over the previous 50/200 days. For BioNTech stocks, the 50-day moving average is the resistance level today.

BioNTech SE (BNTX) Latest Stock News & Headlines - Yahoo Finance U.S. markets closed +26.83 +294.61(+0.82%) Nasdaq +78.81(+0.55%) Russell 2000 +53.62(+2.96%) Crude Oil 74.38 -1.58(-2.08%) Gold...

See if BNTX stock is a buy or sell after earnings. BioNTech has had an excellent 2021. 2022 and beyond will most likely not be this good, however. See if BNTX stock is a buy or sell after earnings.How we approach editorial content. See the latest BioNTech SE ADR stock price (BNTX:XNAS), related news, valuation, dividends and more to help you make your investing decisions.BioNTech (NASDAQ: BNTX), a leader in messenger RNA technology and Pfizer’s Covid-19 vaccine partner, has seen its stock rally from about $80 at the end of 2020 to levels of almost $420 currently ...Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN), like BioNTech SE (NASDAQ:BNTX), and AbbVie Inc. (NYSE:ABBV), is a highly popular biotech stock today, as evidenced by the number of hedge funds ...3 Nov 2022 ... Finance: At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social ...Consider these seven popular names stocks to avoid, as a possible market downturn could knock them down to substantially lower prices. A possible market downturn could knock these stocks down to substantially lower prices Source: Shuttersto...BioNTech SE American Depositary Share (BNTX) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.BioNTech Q3 Profit Falls, Trims FY23 Vaccine Revenue Outlook. RTTNews. Nov. 6, 2023, 08:06 AM. (RTTNews) - BioNTech SE (BNTX) Monday announced a sharp fall in third-quarter earnings compared to ...

BioNTech SE ADR analyst ratings, historical stock prices, earnings estimates & actuals. BNTX updated stock price target summary.Aug 7, 2023 · A monster revenue miss was the big reason for the widespread investor sell-off in BioNTech ( BNTX 0.89%) stock on Monday. As of late-session trading that day, the once-hot biotech's share price ... BioNTech SE. Analyst Report: BioNTech SE BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as ...Get the latest BioNTech SE (BNTX) stock price, news, buy or sell recommendation, and investing advice from Wall Street professionals.Instagram:https://instagram. moving insurance companiesbest masshealth plannasdaq abnbdocusign tock Discover historical prices for BNTX stock on Yahoo Finance. View daily, weekly or monthly format back to when BioNTech SE stock was issued. According to Accountingbase.com, common stock is neither an asset nor a liability; it is considered equity. Equity is basically considered to mathematically be the difference between the total assets and total liabilities of a company. glice skatingcrypto stocks to buy The share price of BioNTech SE (BNTX) now. What analysts predict: $142.42. 52-week High/Low: $188.99 / $88. 50/200 Day Moving Average: $101.74 / $113.19. This figure corresponds to the Average Price over the previous 50/200 days. For BioNTech stocks, the 50-day moving average is the resistance level today.3 days ago ... JPMorgan downgrades BioNTech (BNTX) due to uncertain outlook for COVID-19 vaccine, hurting company's shares in the pre-market. free stock scanner 3. BioNTech. Per its coronavirus vaccine collaboration with Pfizer, BioNTech ( BNTX 1.40%) is the only company on this list that's currently earning revenue as a result of its sales of mRNA ...Jun 18, 2023 · BNTX Stock Assessment. Per Seeking Alpha, BioNTech's stock assessment reveals a mixed bag of results. In terms of valuation, the company is rated "A+" with forward-looking non-GAAP P/E at 20.76 ...